Review of the safety and efficacy of risedronate for the treatment of male osteoporosis

Raja Bobba1, Jonathan D Adachi21Department of Medicine, St. Joseph’s Healthcare - McMaster University, 2Department of Medicine, Alliance for Better Bone Health Chair in Rheumatology, St. Joseph’s Healthcare, McMaster University, Hamilton, ON, CanadaAbstract: Osteoporosis in men i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Raja Bobba, Jonathan D Adachi
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2007
Materias:
Acceso en línea:https://doaj.org/article/b45567b05e58473f8e6434d1cd6ff6ca
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b45567b05e58473f8e6434d1cd6ff6ca
record_format dspace
spelling oai:doaj.org-article:b45567b05e58473f8e6434d1cd6ff6ca2021-12-02T06:16:46ZReview of the safety and efficacy of risedronate for the treatment of male osteoporosis1178-1998https://doaj.org/article/b45567b05e58473f8e6434d1cd6ff6ca2007-10-01T00:00:00Zhttps://www.dovepress.com/review-of-the-safety-and-efficacy-of-risedronate-for-the-treatment-of--peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Raja Bobba1, Jonathan D Adachi21Department of Medicine, St. Joseph’s Healthcare - McMaster University, 2Department of Medicine, Alliance for Better Bone Health Chair in Rheumatology, St. Joseph’s Healthcare, McMaster University, Hamilton, ON, CanadaAbstract: Osteoporosis in men is an increasingly recognized problem with associated fracture morbidity and mortality. Treatment is limited, with the bisphosphonates being the mainstay of therapy. Risedronate has demonstrated fracture efficacy in women and efficacy has been recently been investigated in men. In men, risedronate either maintains or increases bone mineral density. In placebo controlled trials it has been shown to be safe and effective in preventing fractures.Keywords: male osteoporosis, risedronate, bone mineral density, fracturesRaja BobbaJonathan D AdachiDove Medical PressarticleGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 2, Pp 275-282 (2007)
institution DOAJ
collection DOAJ
language EN
topic Geriatrics
RC952-954.6
spellingShingle Geriatrics
RC952-954.6
Raja Bobba
Jonathan D Adachi
Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
description Raja Bobba1, Jonathan D Adachi21Department of Medicine, St. Joseph’s Healthcare - McMaster University, 2Department of Medicine, Alliance for Better Bone Health Chair in Rheumatology, St. Joseph’s Healthcare, McMaster University, Hamilton, ON, CanadaAbstract: Osteoporosis in men is an increasingly recognized problem with associated fracture morbidity and mortality. Treatment is limited, with the bisphosphonates being the mainstay of therapy. Risedronate has demonstrated fracture efficacy in women and efficacy has been recently been investigated in men. In men, risedronate either maintains or increases bone mineral density. In placebo controlled trials it has been shown to be safe and effective in preventing fractures.Keywords: male osteoporosis, risedronate, bone mineral density, fractures
format article
author Raja Bobba
Jonathan D Adachi
author_facet Raja Bobba
Jonathan D Adachi
author_sort Raja Bobba
title Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
title_short Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
title_full Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
title_fullStr Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
title_full_unstemmed Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
title_sort review of the safety and efficacy of risedronate for the treatment of male osteoporosis
publisher Dove Medical Press
publishDate 2007
url https://doaj.org/article/b45567b05e58473f8e6434d1cd6ff6ca
work_keys_str_mv AT rajabobba reviewofthesafetyandefficacyofrisedronateforthetreatmentofmaleosteoporosis
AT jonathandadachi reviewofthesafetyandefficacyofrisedronateforthetreatmentofmaleosteoporosis
_version_ 1718400011275862016